Forum | Friends of Cancer Research

You are here

Forum

Enhancing Patient Input and Regulatory Innovation

A Friends of Cancer Research roundtable with:

Dr. Robert Califf

Deputy Commissioner for Medical Products and Tobacco

U.S. Food and Drug Administration

 

Tuesday May 19, 2015 – 9:00am – 12:00pm 

Blueprint for Drug/Diagnostic Development: Genetic Databases

A Blueprint for Drug/Diagnostic Co-Development:

Genetic Databases

September 9th, 2015 – 9:00am-12:00pm

The Mayflower

1127 Connecticut Ave NW

Washington, DC 20036

A Blueprint for Drug/Diagnostic Co-development: Next-Generation Sequencing (NGS)

In this 3rd installment of the Blueprint for Drug/Diagnostic Co-development, Friends of Cancer Research and Alexandria Real Estate Equities, Inc. brought together researchers, sponsors, advocates, and regulators to discuss possible approaches to expedite development of Next Generation Sequencing (NGS) as a companion diagnostic.

Design of a Colon Cancer Master Protocol (ASSIGN)

Design of a Colon Cancer Master Protocol (ASSIGN), March 7, 2014, Washington DC

A Blueprint for Drug/Diagnostic Co-development: Breakthrough Therapies

On September 6, 2013, Friends of Cancer Research and Alexandria Real Estate Equities, Inc. held their second forum on the co-development of drugs and companion diagnostics. This year's forum brought together researchers, sponsors, advocates, and regulators to discuss possible approaches to the expedited development of a companion diagnostic device (co-Dx) that is intended for use with a Breakthrough Therapy, as well as other issues that will arise from the increased use of co-Dx.

Pages